Table 2.

Tumor marker levels in cyst fluids and serum

	Benign (B) n = 156 median (range)	Borderline (BOT) n = 22 median (range)	B versus BOT P-value	M stage I (Ml) n = 32 median (range)	B versus Ml P-value	All malignant (M) n = 78	B versus M P-value
Cyst fluid
GROa	343 (11–1435)	921 (140–1403)	<0.001*	922 (15–1430)	0.003*	919 (15–1430)	<0.001*
IL-8	756 (1–279,000)	16,712 (99–757,000)	<0.001*	11,903 (11–530,000)	<0.001*	6704 (11–530,000)	<0.001*
MCP-1	10,512 (38–184,000)	93,670 (29–390,000)	<0.001*	27,824 (309–424,000)	0.003*	20,464 (309–424,000)	0.006*
Serum
GROa	58 (18–923)	73 (18–81)	0.09	59 (30–145)	0.411	96 (30–392)	<0.001*
IL-8	7 (3–278)	8 (2–48)	0.590	10 (3–82)	0.006*	13 (3–82)	<0.001*
MCP-1	287 (67–7430)	261 (103–820)	0.75	257 (100–891)	0.303	267 (71–1251)	0.99
CA125	18 (3–716)	52 (7–323)	<0.001*	52 (8–807)	<0.001*	153 (8–955)	<0.001*

GROa, IL-8, and MCP-1 (pg mL); CA125 (U/mL).

^*P < 0.05.